The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

doi:10.1111/bju.15535

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.

BJU international - 1 Mar 2022

Benafif Sarah, Ni Raghallaigh Holly, McGrowder Eva, Saunders Edward J, Brook Mark N, Saya Sibel, Rageevakumar Reshma, Wakerell Sarah, James Denzil, Chamberlain Anthony, Taylor Natalie, Hogben Matthew, Benton Barbara, D'Mello Lucia, Myhill Kathryn, Mikropoulos Christos, Bowen-Perkins Hywel, Rafi Imran, Ferris Michelle, Beattie Andre, Kuganolipava Shophia, Sevenoaks Tamsin, Bower Juliet, Kumar Pardeep, Hazell Steven, deSouza Nandita M, Antoniou Antonis, Bancroft Elizabeth, Kote-Jarai Zsofia, Eeles Rosalind

Abstract excerpt

OBJECTIVES: To assess the feasibility and uptake of a community-based prostate cancer (PCa) screening programme selecting men according to their genetic risk of PCa. To assess the uptake of PCa screening investigations by men invited for screening. The uptake of the pilot study would guide the opening of the larger BARCODE1 study recruiting 5000 men. SUBJECTS AND METHODS: Healthy males aged 55-69 years were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Early Detection of Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feasibility Studies

Share to Germ Cells

Share to Pilot Projects

Share to Polymorphism, Single Nucleotide

Share to Prostate Cancer Diagnosis and Treatment

Share to Prostate-Specific Antigen

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34214236
DOI: 10.1111/bju.15535
PMCID: PMC9292247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening.PMID 34214236Read ↗

Guidelines for genetic testing in prostate cancer: a scoping review.Semantic proximity Read ↗

Assessment of a Polygenic Risk Score in Screening for Prostate CancerSemantic proximity Read ↗

Performance of Three Inherited Risk Measures for Predicting Prostate Cancer Incidence and Mortality: A Population-based Prospective Analysis.Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Men with a susceptibility to prostate cancer and the role of genetic based screeningSemantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation.Semantic proximity Read ↗

Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.Semantic proximity Read ↗

Precision Prostate Cancer Screening with a Polygenic Risk ScoreSemantic proximity Read ↗

Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.Semantic proximity Read ↗

Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK BiobankSemantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.